Furthermore, through an exploratory multivariate analysis, we found that some patients who had low- or intermediate-risk PCa, whose age threshold exceeded 62.5 years, and/or whose serum PSA threshold exceeded 9.4 ng/ml may be more likely had a high uptake of PSMA. The gene discussed is FOLH1; the disease is posterior cortical atrophy.